Back
~
1
min read
· Posted on
February 21, 2024

From RATs to Brats: Atomo pivots from Covid RAT tests to rapid pregnancy kits

Atomo expects their pregnancy test to become their company's main product.

What's the key learning?

  • Atomo's working on a unique blood-based rapid pregnancy test that's apparently going to be more accurate than the current over-the-counter options.
  • Total Addressable Market or TAM is used to reference the total revenue opportunity available for a product or service.
  • Shifting a company's focus to a new product is a risky move, so you want to be sure it'll be worth your while.

👉 Background: Atomo Diagnostics is an ASX-listed medical diagnostics company. They initially made headlines with their HIV rapid self-test, but then pivoted to COVID RAT tests during the pandemic... where they made bank!

👉 What happened: Now, RAT tests have seen their demand drop faster than a New Year's resolution. So, Atomo's looking at a new market: they're working on a unique blood-based rapid pregnancy test that's apparently going to be more accurate than the current over-the-counter options.

👉 What else: After the big pivot, Atomo expects their pregnancy test to become their company's main product. And the global addressable market is worth $2 billion...and growing.

What's the key learning?

💡Total Addressable Market or TAM is used to reference the total revenue opportunity available for a product or service. It's a fancy way of saying "If every star in the universe aligned perfectly, this is how much money we could make."

💡Shifting a company's focus to a new product is a risky move, so you want to be sure it'll be worth your while. That's why understanding the market potential is hugely important.

💡So while TAM can give a nice, rosy picture of potential, it's also important to ground it with realistic growth targets over time.

‍

Ready to win at money?

Sign up for Flux and join 100,000 members of the Flux family

A button to App StoreGoogle Play store button
Excellent  4.9 out of 5
Star rating
No items found.